Quote:

---

[to just propose that leronlimab will mitigate this without proper pre-clinical studies, etc., is irresponsible.

---

Where have I proposed no clinical trials. Of course there would be trials, how else do you get FDA approval, Do you think I'm going to get a hold of some leronlimab and start injecting my friends who might have the flu? Research on a drug first takes someone making a proposal, I just did in this thread.

Quote:

---

[This study is particularly on point as to the complicated relationship between CCR5 and inflammation. In this case, specifically with influenza A:

---

That study is based on CCR5 delete mice. That's not even similar to CCR5 delta 32 because no work-around to the immune system has taken place. With CCR5 delete mice you have a very low immune response right out of the box.

My suggestion was potential with leronlimab when there was an overactive immune response. Definitely apples and oranges.